Skip to main content
Top
Published in: Diabetologia 4/2005

01-04-2005 | Article

High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes

Authors: M. E. Piché, S. Lemieux, L. Pérusse, S. J. Weisnagel

Published in: Diabetologia | Issue 4/2005

Login to get access

Abstract

Aims/hypothesis

The aim of this study was to evaluate differences in insulin sensitivity, insulin secretion and risk factors for cardiovascular disease between subjects with a 2-h plasma glucose (2hPG) level within the normal range (NPG) and subjects with IGT, following a 75-g OGTT. We also aimed to determine the respective contributions made by 2hPG and fasting plasma glucose to the metabolic risk profile.

Methods

We compared cardiovascular risk factors and insulin sensitivity and insulin secretion by using several indices calculated using measurements obtained during an OGTT. Subjects (n=643, age 18–71 years) were participants in the Québec Family Study and were categorised according to 2hPG as having low NPG (2hPG <5.6 mmol/l, the group median for normal values), high NPG (2hPG 5.6–7.7 mmol/l) or IGT (2hPG 7.8–11.0 mmol/l). Subjects with type 2 diabetes were excluded from all analyses.

Results

Beta cell function and insulin sensitivity progressively decreased with increasing 2hPG. Compared with subjects with low NPG, subjects with high NPG were more insulin-resistant (p<0.05) and had reduced insulin secretion (adjusted for insulin resistance) (p<0.001). They also had higher plasma triglyceride concentrations (p<0.01) and cholesterol:HDL cholesterol ratios (p<0.05). These differences remained even after adjustment for age, sex, BMI and waist circumference. Multivariate analyses showed that 2hPG was closely associated with risk factors for diabetes and with cardiovascular variables, including triglycerides (p<0.0001) and apolipoprotein B (p<0.01).

Conclusions/interpretation

These results show that deteriorations in glucose–insulin metabolism, which may predispose individuals to type 2 diabetes and cardiovascular disease, are already present in subjects with 2hPG concentrations within the high normal range. Independently of obesity, 2hPG was found to explain, in part, the variance observed in cardiovascular and diabetes risk factors. In addition, elevated 2hPG was associated with metabolic alterations that appear to be the most detrimental to metabolic health. Thus, 2hPG values within the high normal range may be an important marker for the identification of people at risk of complications related to type 2 diabetes.
Literature
1.
go back to reference National Diabetes Data Group (1979) Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 28:1039–1057 National Diabetes Data Group (1979) Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 28:1039–1057
2.
go back to reference World Health Organization Expert Committee on Diabetes Mellitus (1980) Technical Report Series 646, second report. World Health Organization, Geneva World Health Organization Expert Committee on Diabetes Mellitus (1980) Technical Report Series 646, second report. World Health Organization, Geneva
3.
go back to reference Jarrett RJ, Keen H, Fuller JH, McCartney P (1979) Worsening of diabetes in men with impaired glucose tolerance. Diabetologia 16:25–30 Jarrett RJ, Keen H, Fuller JH, McCartney P (1979) Worsening of diabetes in men with impaired glucose tolerance. Diabetologia 16:25–30
4.
go back to reference World Health Organization Study Group (1999) Report of a WHO consultation Part 1: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organization, Geneva, p 59 World Health Organization Study Group (1999) Report of a WHO consultation Part 1: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organization, Geneva, p 59
5.
go back to reference Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2004) Summary of revisions for the 2004 clinical practice recommendations. Diabetes Care 27 [Suppl 1]:S5–S14 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2004) Summary of revisions for the 2004 clinical practice recommendations. Diabetes Care 27 [Suppl 1]:S5–S14
6.
go back to reference Balkau B, Shipley M, Jarrett RJ et al (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367PubMed Balkau B, Shipley M, Jarrett RJ et al (1998) High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care 21:360–367PubMed
7.
go back to reference Haffner SM (1998) The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 19:583–592CrossRefPubMed Haffner SM (1998) The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. Endocr Rev 19:583–592CrossRefPubMed
8.
go back to reference Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals. The Bruneck Study. Diabetes 53:1782–1789 Bonora E, Kiechl S, Willeit J et al (2004) Population-based incidence rates and risk factors for type 2 diabetes in white individuals. The Bruneck Study. Diabetes 53:1782–1789
9.
go back to reference Rodriguez BL, Lau N, Burchfiel CM et al (1999) Glucose intolerance and 23-years risk of coronary heart disease and total mortality. The Honolulu Heart Program. Diabetes Care 22:920–924 Rodriguez BL, Lau N, Burchfiel CM et al (1999) Glucose intolerance and 23-years risk of coronary heart disease and total mortality. The Honolulu Heart Program. Diabetes Care 22:920–924
10.
go back to reference Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1:1373–1376 Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1:1373–1376
11.
go back to reference Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMed Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–240PubMed
12.
go back to reference Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44:929–945CrossRefPubMed Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44:929–945CrossRefPubMed
13.
go back to reference Resnick HE, Harris MI, Dwight BB, Harris TB (2000) American Diabetes Association diabetes diagnosis criteria, advancing age, and cardiovascular disease risk profiles. Diabetes Care 23:176–180 Resnick HE, Harris MI, Dwight BB, Harris TB (2000) American Diabetes Association diabetes diagnosis criteria, advancing age, and cardiovascular disease risk profiles. Diabetes Care 23:176–180
14.
go back to reference Krauss RM, Winston M, Fletcher RN, Grundy SM (1998) Obesity: impact of cardiovascular disease. Circulation 98:1472–1476 Krauss RM, Winston M, Fletcher RN, Grundy SM (1998) Obesity: impact of cardiovascular disease. Circulation 98:1472–1476
15.
go back to reference Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
16.
go back to reference Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 [Suppl 1]:M9–M16 Ceriello A (2003) The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications. Diabetologia 46 [Suppl 1]:M9–M16
17.
go back to reference DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696 DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696
18.
go back to reference Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T (2000) Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med 17:835–840 Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T (2000) Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes. Diabet Med 17:835–840
19.
go back to reference Bouchard C (1996) Genetics, epidemiology, association, and sib-pair linkage: results from the Québec Family Study. In: Bray GA, Ryan DH (eds) Molecular and genetic aspects of obesity. Louisiana State University Press, Baton Rouge, pp 470–481 Bouchard C (1996) Genetics, epidemiology, association, and sib-pair linkage: results from the Québec Family Study. In: Bray GA, Ryan DH (eds) Molecular and genetic aspects of obesity. Louisiana State University Press, Baton Rouge, pp 470–481
20.
go back to reference Meneely GR, Kaltreider NL (1949) Volume of the lung determined by helium dilution. J Clin Invest 28:129–139 Meneely GR, Kaltreider NL (1949) Volume of the lung determined by helium dilution. J Clin Invest 28:129–139
21.
go back to reference Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239–280 Siri WE (1956) The gross composition of the body. Adv Biol Med Phys 4:239–280
22.
go back to reference The Airlie (VA) Consensus Conference (1988) In: Lohman T, Roche A, Martorel R (eds) Standardization of anthropometric measurements. Human Kinetics Publishers, Champaign, pp 39–80 The Airlie (VA) Consensus Conference (1988) In: Lohman T, Roche A, Martorel R (eds) Standardization of anthropometric measurements. Human Kinetics Publishers, Champaign, pp 39–80
23.
go back to reference Sjöström L, Kvist H, Cederblad A, Tylen U (1986) Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. Am J Physiol 250:E736–E745 Sjöström L, Kvist H, Cederblad A, Tylen U (1986) Determination of total adipose tissue and body fat in women by computed tomography, 40K and tritium. Am J Physiol 250:E736–E745
24.
go back to reference Ferland M, Després JP, Tremblay A et al (1989) Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 61:139–148PubMed Ferland M, Després JP, Tremblay A et al (1989) Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Br J Nutr 61:139–148PubMed
25.
go back to reference Richterich R, Dauwalder H (1971) Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method [in German]. Schweiz Med Wochenschr 101:615–618PubMed Richterich R, Dauwalder H (1971) Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method [in German]. Schweiz Med Wochenschr 101:615–618PubMed
26.
go back to reference Desbuquois B, Aurbach GD (1971) Use polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 37:732–738 Desbuquois B, Aurbach GD (1971) Use polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 37:732–738
27.
go back to reference Heding LG (1975) Immunological determination of human C-peptide in serum. Diabetologia 11:541–548 Heding LG (1975) Immunological determination of human C-peptide in serum. Diabetologia 11:541–548
28.
go back to reference Pascot A, Després JP, Lemieux I et al (2000) Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia 43:1126–1135 Pascot A, Després JP, Lemieux I et al (2000) Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance. Diabetologia 43:1126–1135
29.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMed
30.
go back to reference Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMed Stumvoll M, Mitrakou A, Pimenta W et al (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMed
31.
go back to reference Seltzer HS, Allen W, Herron AL, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323–334PubMed Seltzer HS, Allen W, Herron AL, Brennan MT (1967) Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323–334PubMed
32.
go back to reference Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198 Hanson RL, Pratley RE, Bogardus C et al (2000) Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190–198
33.
go back to reference Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY (1990) Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 71:1447–1453 Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY (1990) Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 71:1447–1453
34.
go back to reference Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175 Cederholm J, Wibell L (1990) Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 10:167–175
35.
go back to reference Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with euglycemic insulin clamp. Diabetes Care 22:1462–1470 Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with euglycemic insulin clamp. Diabetes Care 22:1462–1470
36.
go back to reference Couillard C, Després JP, Lamarche B et al (2001) Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 21:1226–1232 Couillard C, Després JP, Lamarche B et al (2001) Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 21:1226–1232
37.
go back to reference Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45–52 Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45–52
38.
go back to reference Bosello O, Zamboni M (2000) Visceral obesity and metabolic syndrome. Obes Rev 1:47–56 Bosello O, Zamboni M (2000) Visceral obesity and metabolic syndrome. Obes Rev 1:47–56
39.
go back to reference Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMed
40.
go back to reference Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed Kahn SE, Prigeon RL, McCulloch DK et al (1993) Quantification of the relationship between insulin sensitivity and beta cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663–1672PubMed
41.
go back to reference Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456–1467PubMed
42.
go back to reference Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203 Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203
43.
go back to reference Festa A, D’Agostino R, Hanley A, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53:1549–1555 Festa A, D’Agostino R, Hanley A, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53:1549–1555
Metadata
Title
High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes
Authors
M. E. Piché
S. Lemieux
L. Pérusse
S. J. Weisnagel
Publication date
01-04-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1701-y

Other articles of this Issue 4/2005

Diabetologia 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.